v3.26.1
ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Schedule of Divestitures (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Disposal Group, Including Discontinued Operations [Line Items]        
Net Proceeds $ 207 $ 277 $ 508 $ 563
Divestiture (Gains)/Losses (138) 1 (162) (7)
Royalty Income 0 (286) 0 (558)
Diabetes business - royalties        
Disposal Group, Including Discontinued Operations [Line Items]        
Net Proceeds 0 276 273 552
Divestiture (Gains)/Losses 0 0 0 0
Royalty Income 0 (286) 0 (558)
Mature products and other        
Disposal Group, Including Discontinued Operations [Line Items]        
Net Proceeds 207 1 235 11
Divestiture (Gains)/Losses (138) 1 (162) (7)
Royalty Income 0 $ 0 $ 0 $ 0
Sino-American Shanghai Squibb Pharmaceuticals Limited        
Disposal Group, Including Discontinued Operations [Line Items]        
Cash proceeds 164      
Gain on divestiture $ 109      
Percent of ownership stake 60.00%   60.00%